Andrew Kirsteins, MD
Interventional Pain Medicine · Greensboro, NCNPI 1053394254
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in NC, where the typical reported total is $2,787.
Across 153 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$602
- Ipsen Biopharmaceuticals, Inc$455
- Collegium Pharmaceutical, Inc.$400
- Merz Pharmaceuticals, LLC$283
- SPR Therapeutics, Inc$244
- Boston Scientific$239
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $602 |
| Ipsen Biopharmaceuticals, Inc | 24 | $455 |
| Collegium Pharmaceutical, Inc. | 22 | $400 |
| Merz Pharmaceuticals, LLC | 11 | $283 |
| SPR Therapeutics, Inc | 5 | $244 |
| Boston Scientific | 5 | $239 |
| Averitas Pharma Inc. | 9 | $215 |
| Microtransponder, Inc. | 5 | $152 |
| Vertex | 5 | $124 |
| Lundbeck LLC | 6 | $105 |
| Supernus Pharmaceuticals, Inc. | 6 | $85 |
| Fujifilm Sonosite, Inc. | 1 | $76 |
| Avanos Medical | 3 | $68 |
| Pacira Therapeutics, Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $37 |
| Novartis | 2 | $31 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| GRT US Holding, Inc. | 1 | $24 |
| Merz North America, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Acelrx Pharmaceuticals, Inc. | 1 | $20 |
| Si-bone, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Pfizer | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,380 in reported general payments places this provider in the 50th percentile of 45 interventional pain medicine providers in North Carolina.
See all interventional pain medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 106 | $1,922 |
| Pregabalin | 61 | $1,264 |
| Baclofen | 68 | $1,100 |
| Tramadol Hcl | 126 | $912 |
| Nortriptyline Hcl | 36 | $647 |
| Duloxetine Hcl | 44 | $608 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $599 |
| Tizanidine Hcl | 75 | $597 |
| Cyclobenzaprine Hcl | 40 | $566 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $522 |
| Clonazepam | 18 | $236 |
| Oxycodone Hcl | 11 | $205 |
| Methocarbamol | 14 | $134 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $85 |
| Topiramate | 14 | $76 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Greensboro
- Gregory CrispGreensboro$526
- Timothy ChafinAhoskie$59K
- Robert WilsonSalisbury$37K
- John MansfieldAsheville$25K
- Erin ChaneyJacksonville$22K
- Kevin CostelloGreenville$22K
- Scott JohnstonJacksonville$20K
- Harsh GovilStatesville$19K
- Troy GingerichCharlotte$19K
- Brent HarkriderNew Bern$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.